MAPT and Alzheimer disease: To establish myelin loss as a major contributor to cognitive impairment in the context of AD, temporal dynamics of demyelination should be examined in other AD models, including those modeling tau pathology (Yoshiyama et al., 2007) and second-generation mouse models that have been generated to overcome the intrinsic drawbacks of the overexpression paradigm (Sasaguri et al., 2017).